SCHEMBL6094956

SCHEMBL6094956

O=C1C=C(Cl)C(=O)C(c2c[nH]c3cc(Cl)ccc23)=C1Cl

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.43
IDH1 O75874 1/20 0.42
DYRK1A Q13627 2/20 0.42
GPR84 Q9NQS5 1/20 0.42
GSK3B P49841 1/20 0.41
NR4A2 P43354 1/20 0.39
IDO1 P14902 1/20 0.39
MDM2 Q00987 3/20 0.38
CDK4 P11802 2/20 0.38
CCND1 P24385 2/20 0.38
PRKCB P05771 3/20 0.37
PRKCA P17252 2/20 0.37
PRKCH P24723 2/20 0.37
PRKCE Q02156 2/20 0.37
PRKCQ Q04759 2/20 0.37
PRKCD Q05655 2/20 0.37
DAO P14920 1/20 0.37
PTPN1 P18031 1/20 0.36
PARP1 P09874 1/20 0.36
TP53 P04637 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6098311 0.89 F7 (0.43) ALDH1A1GPR84NR4A2IDO1CAMK2D
SCHEMBL6095486 0.86 TDO2 (0.46) GPR84IDO1CDK4CCND1CCNE2
SCHEMBL6094623 0.86 IMPDH2 (0.45) GSK3BIDO1CDK4CCND1CCNB2
SCHEMBL6098483 0.86 MEN1 (0.40) IDH1NR4A2IDO1CDK4CCND1
SCHEMBL6097734 0.83 PRKCB (0.54) GSK3BCDK4CCND1PRKCBPRKCA
SCHEMBL6098129 0.78 EGFR (0.44) GPR84GSK3BNR4A2IDO1CCNB2
SCHEMBL6096429 0.78 IGF1R (0.44) GPR84IDO1PIM1CAMK2DSLC6A4
SCHEMBL6095976 0.78 TSHR (0.39) ALDH1A1PTPN1SLC6A4
SCHEMBL6094987 0.78 MEN1 (0.41) NR4A2IDO1PRKCBTP53SMN1; SMN2
SCHEMBL6099166 0.77 CDK4 (0.39) ALDH1A1GSK3BCDK4CCND1ABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7057052-B2 Heterocyclic quinones as pharmaceutical agents DUKE UNIVERSITY (US) 2006-06-06 US disclosed
WO-2004050014-A2 SETEROCYCLIC QUINONES AS PHARMACEUTICAL AGENTS DUKE UNIVERSITY (US) 2004-06-17 WO disclosed
US-20040063774-A1 Heterocyclic quinones as pharmaceutical agents DUKE UNIVERSITY 2004-04-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040063774-A1 Heterocyclic quinones as pharmaceutical agents NQO1, RECQL, SDHA ALDH1A1 609/4885IDH1 46/4885DYRK1A 2359/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.